Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27553313 | 0.86 | SOS1 (0.31) | SOS1SOS2 | |
| SCHEMBL10893120 | 0.83 | ALOX15 (0.30) | — | |
| SCHEMBL6838356 | 0.80 | TSHR (0.35) | SOS1SOS2 | |
| SCHEMBL28153211 | 0.80 | GNAO1 (0.36) | SOS1SOS2 | |
| SCHEMBL6380836 | 0.77 | SOS1 (0.34) | SOS1SOS2 | |
| Bromide SCHEMBL6291796 | 0.76 | GNAO1 (0.36) | — | |
| SCHEMBL9000042 | 0.75 | ALOX15 (0.32) | SOS1SOS2 | |
| Piperazine SCHEMBL28225897 | 0.74 | SOS1 (0.32) | SOS1SOS2 | |
| SCHEMBL7026604 | 0.74 | SOS1 (0.33) | SOS1SOS2 | |
| SCHEMBL28142685 | 0.74 | SOS1 (0.47) | SOS1SOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120028979-A1 | 2-(PIPERIDIN-1-YL)-4-HETEROCYCLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS | ASTRAZENECA AB (SE) | 2012-02-02 | — | — | US | disclosed |
| EP-1593701-A1 | Curable resin composition | Ajinomoto Co., Inc. (JP) | 2005-11-09 | — | — | EP | disclosed |
| EP-0950677-B1 | Curable resin composition | AJINOMOTO KK (JP) | 2005-10-19 | — | — | EP | disclosed |
| US-6482899-B2 | LATENCY CURING AGENTS; STORAGE STABILITY | AJINOMOTO CO., INC. (JP) | 2002-11-19 | — | — | US | disclosed |
| US-20020010287-A1 | Latency curing agents; storage stability | AJINOMOTO CO., INC. (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-0950677-A2 | Curable resin composition | Ajinomoto Co., Inc. (JP) | 1999-10-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028979-A1 | 2-(PIPERIDIN-1-YL)-4-HETEROCYCLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS | TLR5, TLR2, PIR | SOS1 2845/4885SOS2 3127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.